1.
Peters A. Safety and tolerability of Bruton’s tyrosine kinase inhibitors in the treatment of Waldenström macroglobulinemia. Can Hematol Today [Internet]. 2022 Jun. 15 [cited 2024 Dec. 21];1(S06). Available from: https://canadianhematologytoday.com/article/view/28